The future of medicinal cannabis: patient need v public policy and regulation

While products containing THC levels in excess of 0.2% are generally prohibited in Europe and classified as “controlled substances”, CBD is not classified as such. As a result, there are a number of unregulated CBD products on the market which may have little or no effect.

https://www.lexology.com/library/detail.aspx?g=ec2bb4c1-8e62-4526-8865-105f50d77790

Leave a Reply